Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Gilbert

Showing results (11-20 of 337) with videos related to

Pageof 34
Sort By:
Biostatistics (Oxford, England)|April 16, 2005
Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiationPeter B Gilbert, Yanqing Sun
The Lancet. Haematology|February 9, 2016
Search continues for a CMV vaccine for transplant recipientsMichael Boeckh, Peter B Gilbert
Lifetime Data Analysis|March 24, 2016
Joint modeling of longitudinal and survival data with the Cox model and two-phase samplingRong Fu, Peter B Gilbert
Plos Pathogens|March 25, 2021
Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protectionMorgane Rolland, Peter B Gilbert
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Nomenclature for immune correlates of protection after vaccinationStanley A Plotkin, Peter B Gilbert
Biometrics|April 29, 2009
Assessing vaccine effects in repeated low-dose challenge experimentsMichael G Hudgens, Peter B Gilbert
Biostatistics (Oxford, England)|December 17, 2013
Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacyErin E Gabriel, Peter B Gilbert
Biometrics|March 28, 2008
Evaluating candidate principal surrogate endpointsPeter B Gilbert, Michael G Hudgens
Contemporary Clinical Trials|August 23, 2005
Accuracy and precision of estimating intervention efficacy when the timing of observed events differ by treatment armAmalia S Meier, Peter B Gilbert
Journal of Virology|June 14, 2019
Revisiting the Correlate of Reduced HIV Infection Risk in the Rv144 Vaccine TrialSusan Zolla-Pazner, Peter B Gilbert
Pageof 34

Showing results (11-20 of 337) with videos related to

Sort By:
Pageof 34
Biostatistics (Oxford, England)|April 16, 2005
Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiationPeter B Gilbert, Yanqing Sun
The Lancet. Haematology|February 9, 2016
Search continues for a CMV vaccine for transplant recipientsMichael Boeckh, Peter B Gilbert
Lifetime Data Analysis|March 24, 2016
Joint modeling of longitudinal and survival data with the Cox model and two-phase samplingRong Fu, Peter B Gilbert
Plos Pathogens|March 25, 2021
Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protectionMorgane Rolland, Peter B Gilbert
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Nomenclature for immune correlates of protection after vaccinationStanley A Plotkin, Peter B Gilbert
Biometrics|April 29, 2009
Assessing vaccine effects in repeated low-dose challenge experimentsMichael G Hudgens, Peter B Gilbert
Biostatistics (Oxford, England)|December 17, 2013
Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacyErin E Gabriel, Peter B Gilbert
Biometrics|March 28, 2008
Evaluating candidate principal surrogate endpointsPeter B Gilbert, Michael G Hudgens
Contemporary Clinical Trials|August 23, 2005
Accuracy and precision of estimating intervention efficacy when the timing of observed events differ by treatment armAmalia S Meier, Peter B Gilbert
Journal of Virology|June 14, 2019
Revisiting the Correlate of Reduced HIV Infection Risk in the Rv144 Vaccine TrialSusan Zolla-Pazner, Peter B Gilbert
Pageof 34